IGG SUBTYPE IS CORRELATED WITH EFFICIENCY OF PASSIVE PROTECTION AND EFFECTOR FUNCTION OF ANTI-HERPES SIMPLEX VIRUS GLYCOPROTEIN-D MONOCLONAL-ANTIBODIES

被引:50
作者
ISHIZAKA, ST [1 ]
PIACENTE, P [1 ]
SILVA, J [1 ]
MISHKIN, EM [1 ]
机构
[1] LEDERLE PRAXIS BIOL,DEPT VIRAL VACCINE RES & DEV,PEARL RIVER,NY 10965
关键词
D O I
10.1093/infdis/172.4.1108
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IgG subclasses differ in their effector functions in a variety of in vitro assays. To assess the effect of antibody subclass differences on in vivo protective efficacy against herpes simplex virus (HSV), a series of subclass switch mutants was made from an anti-HSV glycoprotein D monoclonal antibody. Purified antibody was examined for the ability to protect against HSV-2 challenge in mice. IgG2a was found to be more effective than IgG1. This correlated both with activity in antibody-dependent cell-mediated cytotoxicity and with efficiency of complement-mediated neutralization. These data suggest that optimization of passive immunization against HSV requires consideration of antibody subclass.
引用
收藏
页码:1108 / 1111
页数:4
相关论文
共 17 条
[1]   PROTECTION AGAINST LETHAL CHALLENGE OF BALB/C MICE BY PASSIVE TRANSFER OF MONOCLONAL-ANTIBODIES TO 5 GLYCOPROTEINS OF HERPES-SIMPLEX VIRUS TYPE-2 [J].
BALACHANDRAN, N ;
BACCHETTI, S ;
RAWLS, WE .
INFECTION AND IMMUNITY, 1982, 37 (03) :1132-1137
[2]   MODULATION OF ACUTE AND LATENT HERPES-SIMPLEX VIRUS-INFECTION IN C57BL/6 MICE BY ADOPTIVE TRANSFER OF IMMUNE LYMPHOCYTES WITH CYTOLYTIC ACTIVITY [J].
BONNEAU, RH ;
JENNINGS, SR .
JOURNAL OF VIROLOGY, 1989, 63 (03) :1480-1484
[3]  
DUBIN G, 1991, J VIROL, V65, P46
[4]   ANTI-GLYCOPROTEIN-D ANTIBODIES THAT PERMIT ADSORPTION BUT BLOCK INFECTION BY HERPES-SIMPLEX VIRUS-1 PREVENT VIRION CELL-FUSION AT THE CELL-SURFACE [J].
FULLER, AO ;
SPEAR, PG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (15) :5454-5458
[5]   GLYCOPROTEIN-C OF HERPES-SIMPLEX VIRUS TYPE-1 PREVENTS COMPLEMENT-MEDIATED CELL-LYSIS AND VIRUS NEUTRALIZATION [J].
HARRIS, SL ;
FRANK, I ;
YEE, A ;
COHEN, GH ;
EISENBERG, RJ ;
FRIEDMAN, HM .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (02) :331-337
[6]  
KOHL S, 1983, IMMUNOLOGY, V48, P187
[7]  
KUMEL G, 1985, J VIROL, V56, P930
[8]   BACULOVIRUS-EXPRESSED HERPES-SIMPLEX VIRUS TYPE-2 GLYCOPROTEIN-D IS IMMUNOGENIC AND PROTECTIVE AGAINST LETHAL HSV CHALLENGE [J].
LANDOLFI, V ;
ZARLEY, CD ;
ABRAMOVITZ, AS ;
FIGUEROA, N ;
WU, SL ;
BLASIAK, M ;
ISHIZAKA, ST ;
MISHKIN, EM .
VACCINE, 1993, 11 (04) :407-414
[9]   PROTECTION OF MICE FROM LETHAL HERPES-SIMPLEX VIRUS-INFECTION BY VACCINATION WITH A SECRETED FORM OF CLONED GLYCOPROTEIN-D [J].
LASKY, LA ;
DOWBENKO, D ;
SIMONSEN, CC ;
BERMAN, PW .
BIO-TECHNOLOGY, 1984, 2 (06) :527-532